{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T23:30:32Z","timestamp":1773790232405,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1982,1,1]],"date-time":"1982-01-01T00:00:00Z","timestamp":378691200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[1982]]},"DOI":"10.1007\/bf00541166","type":"journal-article","created":{"date-parts":[[2004,11,19]],"date-time":"2004-11-19T03:47:15Z","timestamp":1100836035000},"page":"133-136","source":"Crossref","is-referenced-by-count":10,"title":["In vitro cytotoxicity of human endothelial cells in polymyalgia rheumatica and giant cell arteritis"],"prefix":"10.1007","volume":"2","author":[{"given":"T. S.","family":"Bocanegra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. F.","family":"Germain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. I.","family":"Saba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. H.","family":"Bridgeford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. R.","family":"Saba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. B.","family":"Lowenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. B.","family":"Vasey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. R.","family":"Espinoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"845","DOI":"10.7326\/0003-4819-77-6-845","volume":"77","author":"P Fauchald","year":"1972","unstructured":"Fauchald P, Rygvold O, Osystese B (1972) Temporal arteritis and polymyalgia rheumatica. Clinical and biopsy findings. Ann Intern Med 77:845?852","journal-title":"Ann Intern Med"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.0954-6820.1977.tb15683.x","volume":"201","author":"PS Sorenson","year":"1977","unstructured":"Sorenson PS, Lorenzen I (1977) Giant cell arteritis, temporal arteritis and polymyalgia rheumatica. A retrospective study of 63 patients. Acta Med Scand 201:207?213","journal-title":"Acta Med Scand"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-197101000-00001","volume":"50","author":"CR Hamilton Jr","year":"1971","unstructured":"Hamilton CR Jr, Shelley WM, Tumulty PA (1971) Giant cell arteritis: including temporal arteritis and polymyalgia rheumatica. Medicine 50:1?27","journal-title":"Medicine"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"162","DOI":"10.7326\/0003-4819-88-2-162","volume":"88","author":"KA Huston","year":"1978","unstructured":"Huston KA, Hunder GG, Lie JT, Kennedy RH, Elveback LR (1978) Temporal arteritis: a 25 year epidemiologic, clinical, and pathological study. Ann Intern Med 88:162?167","journal-title":"Ann Intern Med"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1084\/jem.149.6.1326","volume":"149","author":"MB Kahaleh","year":"1979","unstructured":"Kahaleh MB, Sherer GK, LeRoy EC (1979) Endothelial injury in scleroderma. J Exp Med 149:1326?1335","journal-title":"J Exp Med"},{"key":"CR6","first-page":"663","volume":"23","author":"S Cohen","year":"1980","unstructured":"Cohen S, Johnson A, Ziff M, Hurd E (1980) Cytotoxicity of sera from patients with scleroderma or mixed connective tissue disease for human pulmonary arterial and umbilical venous endothelial cells and human fibroblasts in culture. Arthritis Rheum 23:663 (Abstr)","journal-title":"Arthritis Rheum"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/ard.38.5.434","volume":"38","author":"HAW Bird","year":"1979","unstructured":"Bird HAW, Essenlick AJ, Dixon AJ, Mowat AG, Wood PH (1979) An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 38:434?439","journal-title":"Ann Rheum Dis"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/art.1780150512","volume":"15","author":"AS Cohen","year":"1972","unstructured":"Cohen AS, Canoso JJ (1972) Criteria for the classification of systemic Lupus erythematosus-status 1972. Arthritis Rheum 15:540?543","journal-title":"Arthritis Rheum"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0049-3848(78)90311-0","volume":"12","author":"HI Saba","year":"1978","unstructured":"Saba HI, Hartman RC, Saba SR (1978) Effects of polymorphonuclear leukocytes on endothelial cell growth. Thromb Res 12:397?407","journal-title":"Thromb Res"},{"key":"CR10","first-page":"135","volume-title":"A short textbook of medical statistics","author":"AB Hill","year":"1977","unstructured":"Hill AB (1977) A short textbook of medical statistics. Lippincott, Philadelphia, Pennsylvania, pp 135?136"},{"key":"CR11","first-page":"595","volume":"292","author":"M Rosenthal","year":"1975","unstructured":"Rosenthal M, M\u00fcller W, Albert ED, Schattenkirchner M (1975) HLA antigents in polymyalgia rheumatica. N Engl J Med 292:595","journal-title":"N Engl J Med"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1136\/bmj.2.6093.989","volume":"2","author":"B Hazleman","year":"1978","unstructured":"Hazleman B, Goldsone A, Voak D (1978) Association of polymyalgia rheumatica and giant cell arteritis with HLA-B8. Br Med J 2:989?990","journal-title":"Br Med J"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0140-6736(75)90547-4","volume":"II","author":"PA Bacon","year":"1975","unstructured":"Bacon PA, Doherty SM, Zuckerman AJ (1975) Hepatitis B antibody in polymyalgia rheumatica. Lancet II:476?478","journal-title":"Lancet"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0140-6736(78)90703-1","volume":"I","author":"B Plouvier","year":"1978","unstructured":"Plouvier B, Wattre P, Cevulder B (1978) HBsAG in superficial artery of a patient with polymyalgia rheumatica. Lancet I: 932?933","journal-title":"Lancet"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/ard.34.2.122","volume":"34","author":"BC Hazleman","year":"1975","unstructured":"Hazleman BC, Maclennan ICM, Esiri MM (1975) Lymphocyte proliferation to artery antigens as a positive diagnostic test in polymyalgia rheumatica. Ann Rheum Dis 34:122?127","journal-title":"Ann Rheum Dis"},{"key":"CR16","first-page":"321","volume":"4","author":"GG Hunder","year":"1977","unstructured":"Hunder GG, Taswell HD, Pineda AA, Elveback LR (1977) HLA antigens in patients with giant cell arteritis and polymyalgia rheumatica. J Rheumatol 4:321?323","journal-title":"J Rheumatol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/art.1780230417","volume":"23","author":"PH Bridgeford","year":"1980","unstructured":"Bridgeford PH, Lowenstein M, Bocanegra TS, Vasey FB, Germain BF, Espinoza LR (1980) Polymyalgia rheumatica and giant cell arteritis; Histocompatibility typing and hepatitis-B infection studies. Arthritis Rheum 23:516?518","journal-title":"Arthritis Rheum"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0140-6736(76)92944-5","volume":"I","author":"M Liang","year":"1976","unstructured":"Liang M, Greenberg H, Pincus T, Robinson WS (1976) Hepatitis-B antibody in polymyalgia rheumatica. Lancet I:43","journal-title":"Lancet"},{"key":"CR19","first-page":"286","volume":"36","author":"P Zilko","year":"1977","unstructured":"Zilko P, Currey HL, Vernon-Roberts B (1977) Polymyalgia rheumatica (PMR) and giant cell arteritis. Lack of response of peripheral blood lymphocytes to arterial wall homogenate. Ann Rheum Dis 36:286?287 (Abstr)","journal-title":"Ann Rheum Dis"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/art.1780220708","volume":"22","author":"CC Papaioannou","year":"1979","unstructured":"Papaioannou CC, Hunder GG, McDuffie FC (1979) Cellular immunity in polymyalgia rheumatica and giant cell arteritis. Lack of response to muscle or artery homogenates. Arthritis Rheum 22:740?745","journal-title":"Arthritis Rheum"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/art.1780230909","volume":"23","author":"CC Papaioannou","year":"1980","unstructured":"Papaioannou CC, Gupta RC, Hunder GG, McDuffie FC (1980) Circulating immune complexes in giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum 23:1021?1025","journal-title":"Arthritis Rheum"},{"key":"CR22","unstructured":"Espinoza LR, Bridgeford PH, Lowenstein M, Bocanegra TS, Vasey FB, Germain BF (1981) Polymyalgia rheumatica and giant cell arteritis: Circulating immune complexes. Correlation with disease activity. J Rheumatol (in press)"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/path.1710980105","volume":"98","author":"WG Spector","year":"1969","unstructured":"Spector WG, Heeson N (1969) The production of granulomata by antigen antibody complexes. J Pathol 98:31?39","journal-title":"J Pathol"},{"key":"CR24","first-page":"803","volume":"93","author":"G Thorgeirsson","year":"1978","unstructured":"Thorgeirsson G, Robertson AL (1978) The vascular endothelium-pathobiologic significance. A review. Am J Pathol 93:803?484","journal-title":"Am J Pathol"},{"key":"CR25","first-page":"616","volume":"22","author":"RG Grau","year":"1979","unstructured":"Grau RG, Kassan SS, Franks JJ, Kaplan H, Tan EM (1979) Evidence for intracascular coagulation in polymyalgia rheumatica and temporal arteritis. Arthritis Rheum 22:616 (Abstr)","journal-title":"Arthritis Rheum"},{"key":"CR26","unstructured":"Kahaleh MB, Osborn I, LeRoy EC (1981) Endothelial cell cytotoxic factor (ECF) in scleroderma (SCL). Clin Res 29: 166 A (Abstr)"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"482","DOI":"10.7326\/0003-4819-94-4-482","volume":"94","author":"MB Kahaleh","year":"1981","unstructured":"Kahaleh MB, Osborn I, ALeRoy EC (1981) Increased factor VIII\/von Willebrand factor antigen and von Willebrand factor activity in Scleroderma and in Raynoud's phenomenon. Ann Intern Med 94:482?484","journal-title":"Ann Intern Med"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00541166.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00541166\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00541166","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T22:33:29Z","timestamp":1554417209000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00541166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1982]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1982]]}},"alternative-id":["BF00541166"],"URL":"https:\/\/doi.org\/10.1007\/bf00541166","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1982]]}}}